← Open Payments lookup

KELSEY CUMMINGS: Open Payments

NPI 1700669686 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$270 in 8 payments from 7 companies in 2025. Trend: 2023 $33 · 2024 $482 · 2025 $270

Food & beverage: $270
CompanyPaymentsAmount
Alexion Pharmaceuticals, Inc.1$106
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$43
Astellas Pharma US Inc1$30
Merck Sharp & Dohme LLC1$27
Ipsen Biopharmaceuticals, Inc1$25
Veloxis Pharmaceuticals, Inc.1$23
Bayer Healthcare Pharmaceuticals Inc.1$16

Products named: ULTOMIRIS, XIFAXAN, Cresemba, PREVYMIS, IQIRVO, ENVARSUS, Kerendia.

Industry payments across DC — which companies pay providers there.